Mayfair Pharmacare Limited - Accounts to registrar (filleted) - small 18.2
Mayfair Pharmacare Limited - Accounts to registrar (filleted) - small 18.2
REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 30th April 2018 |
for |
MAYFAIR PHARMACARE LIMITED |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Contents of the Financial Statements |
for the year ended 30th April 2018 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 4 |
Chartered Accountants' Report | 9 |
MAYFAIR PHARMACARE LIMITED |
Company Information |
for the year ended 30th April 2018 |
DIRECTOR: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
2 Burton House |
Repton Place |
White Lion Road |
Amersham |
Buckinghamshire |
HP7 9LP |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Balance Sheet |
30th April 2018 |
2018 | 2017 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
Tangible assets | 5 |
Investment property | 6 |
CURRENT ASSETS |
Stocks |
Debtors | 7 |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
9 |
( |
) |
( |
) |
PROVISIONS FOR LIABILITIES | ( |
) |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 11 |
Retained earnings |
SHAREHOLDERS' FUNDS |
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Balance Sheet - continued |
30th April 2018 |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the director on |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Notes to the Financial Statements |
for the year ended 30th April 2018 |
1. | STATUTORY INFORMATION |
Mayfair Pharmacare Limited is a |
Wales. The company's registered number and registered office address can be found on the Company |
Information page. |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover represents sales of goods and services, excluding value added tax. |
Goodwill |
Goodwill, being the amount paid in connection with the acquisition of intangible assets is being |
amortised evenly over its estimated useful life of ten years. |
Intangible assets |
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured |
at cost less any accumulated amortisation and any accumulated impairment losses. |
Tangible fixed assets |
Leasehold property | - over lease term |
PLant and machinery | - 25% straight line |
Fixtures, fittings and equipment | - 20% straight line |
Investment property |
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from |
changes in fair value is recognised in profit or loss. |
Stocks |
Stocks are valued at the lower of cost and net realisable value, after making due allowance for |
obsolete and slow moving items. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, |
except to the extent that it relates to items recognised in other comprehensive income or directly in |
equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been |
enacted or substantively enacted by the balance sheet date. |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Notes to the Financial Statements - continued |
for the year ended 30th April 2018 |
2. | ACCOUNTING POLICIES - continued |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at |
the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods |
different from those in which they are recognised in financial statements. Deferred tax is measured |
using tax rates and laws that have been enacted or substantively enacted by the year end and that are |
expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable |
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Hire purchase and leasing commitments |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the |
period of the lease. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the |
company's pension scheme are charged to profit or loss in the period to which they relate. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | INTANGIBLE FIXED ASSETS |
Goodwill |
£ |
COST |
At 1st May 2017 |
and 30th April 2018 |
AMORTISATION |
At 1st May 2017 |
Charge for year |
At 30th April 2018 |
NET BOOK VALUE |
At 30th April 2018 |
At 30th April 2017 |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Notes to the Financial Statements - continued |
for the year ended 30th April 2018 |
5. | TANGIBLE FIXED ASSETS |
Plant and |
Land and | machinery |
buildings | etc | Totals |
£ | £ | £ |
COST |
At 1st May 2017 |
Additions |
At 30th April 2018 |
DEPRECIATION |
At 1st May 2017 |
Charge for year |
At 30th April 2018 |
NET BOOK VALUE |
At 30th April 2018 |
At 30th April 2017 |
6. | INVESTMENT PROPERTY |
Total |
£ |
FAIR VALUE |
At 1st May 2017 |
and 30th April 2018 |
NET BOOK VALUE |
At 30th April 2018 |
At 30th April 2017 |
7. | DEBTORS |
2018 | 2017 |
£ | £ |
Amounts falling due within one year: |
Trade debtors |
Amounts owed by group undertakings |
Amounts owed by participating interests | - | 17,227 |
Other debtors |
Amounts falling due after more than one year: |
Other debtors |
Aggregate amounts |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Notes to the Financial Statements - continued |
for the year ended 30th April 2018 |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2018 | 2017 |
£ | £ |
Bank loans and overdrafts |
Trade creditors |
Amounts owed to participating interests | 402,052 | 401,160 |
Taxation and social security |
Other creditors |
9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
2018 | 2017 |
£ | £ |
Bank loans |
Other creditors |
Amounts falling due in more than five years: |
Repayable otherwise than by instalments |
Other loans more 5yrs non-inst |
Repayable by instalments |
Bank loans more 5 yr by instal | - | 15,305 |
10. | SECURED DEBTS |
The following secured debts are included within creditors: |
2018 | 2017 |
£ | £ |
Bank overdraft |
Bank loans |
The company's bank facilities are secured by a fixed and floating charge over the assets of the |
company. In addition, the directors have provided personal guarantees for £50,000. |
MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
Notes to the Financial Statements - continued |
for the year ended 30th April 2018 |
11. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2018 | 2017 |
value: | £ | £ |
Ordinary | £1 | 100 | 100 |
Ordinary "A" | £1 | 75 | 75 |
Ordinary "B" | £1 | 25 | 25 |
200 | 200 |
12. | RELATED PARTY DISCLOSURES |
The company is related to Radiant Medicare Limited (RML) by virtue of common shareholding. RML |
also holds 26% of the issued share capital of the company and has injected funds in the form of long |
term loans. At the balance sheet date the company owed RML £402,052 (2017: £402,052). |
There are no repayment terms or interest charges applying to either of the loans referred to above. |
13. | ULTIMATE CONTROLLING PARTY |
There is no single ultimate controlling party. |
Chartered Accountants' Report to the Director |
on the Unaudited Financial Statements of |
Mayfair Pharmacare Limited |
The following reproduces the text of the report prepared for the director in respect of the company's |
annual unaudited financial statements. In accordance with the Companies Act 2006, the company is |
only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain |
other primary statements and the Report of the Director are not required to be filed with the Registrar |
of Companies. |
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval |
the financial statements of Mayfair Pharmacare Limited for the year ended 30th April 2018 which comprise |
the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and |
the related notes from the company's accounting records and from information and explanations you have |
given us. |
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance. |
This report is made solely to the director of Mayfair Pharmacare Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Mayfair Pharmacare Limited and state those matters that we have agreed to state to the director of Mayfair Pharmacare Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mayfair Pharmacare Limited and its director for our work or for this report. |
It is your duty to ensure that Mayfair Pharmacare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Mayfair Pharmacare Limited. You consider that Mayfair Pharmacare Limited is exempt from the statutory audit requirement for the year. |
We have not been instructed to carry out an audit or a review of the financial statements of Mayfair Pharmacare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. |
2 Burton House |
Repton Place |
White Lion Road |
Amersham |
Buckinghamshire |
HP7 9LP |